Hollencrest Capital Management Lannett CO Inc Transaction History

Hollencrest Capital Management

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	BUY	$4.17 - $5.74 $375,300 - $516,600	90,000 Added 290.32%	121,000 $565,000
Q3 2019 Oct 23, 2019	BUY	$5.58 - $14.47 $86,490 - $224,285	15,500 Added 100.0%	31,000 $347,000
Q3 2017 Oct 10, 2017	BUY	$15.1 - $19.25 $234,050 - $298,375	15,500	15,500 $286,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Hollencrest Capital Management, based on Form 13F filings with the SEC.

Stay updated on Hollencrest Capital Management with notifications on news.